Opinion on Pharmaceuticals and Healthcare in North America

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Expert View
Expert View

Inoculating the cancer market

Published By Datamonitor
13 Oct 2000
CommentWire
CommentWire

Statins: new data, same game for BMS

Published By Datamonitor
18 Oct 2000
CommentWire
CommentWire

BMS and Novartis: linking up to stay independent

Published By Datamonitor
18 Oct 2000
CommentWire
CommentWire

Biogen champions a new indication for Avonex

Published By Datamonitor
19 Oct 2000
CommentWire
CommentWire

Myriad Genetics: an unusually successful collaborator

Published By Datamonitor
23 Oct 2000
CommentWire
CommentWire

DuPont: regaining a foothold in the thrombosis market?

Published By Datamonitor
25 Oct 2000
CommentWire
CommentWire

eProcurement: Medical Columbus may suffer in the New World

Published By Datamonitor
27 Oct 2000
Expert View
Expert View

Compliance is just a click away

Published By Datamonitor
03 Nov 2000
CommentWire
CommentWire

KS BioMedix: an alternative route to the marketplace

Published By Datamonitor
06 Nov 2000
CommentWire
CommentWire

Flu remedies: out in the cold

Published By Datamonitor
08 Nov 2000

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.